Skip to content
Research Article Open access CC BY 4.0

Parameters of Systemic Inflammatory Response in Patients with Passing Infringements of Brain Blood Circulation

Natallia V. Halinouskaya, Maria N. Starodubtseva, Evgenii V. Voropaev, Nadzeya M. Halubykh, Sergey V. Samsonau, Vasiliy B. Smychek

Journal of Advances in Medicine and Medical Research · pp. 1–10 · Published 14 Apr 2016

10.9734/BJMMR/2016/24901

Abstract

Aims: The paper aims at revealing the difference in the change of Systemic Inflammation (SI) parameters in blood plasma of patients with Passing Infringements of Brain Blood Circulation (PIBBC) and stroke during 10-day acute period. Study Design: Prospective cohort study. Place and Duration of Study: Department of Neurology and Neurosurgery of the Gomel State Medical University, Stroke Unit of the Gomel Regional Veterans Hospital, between May 2013 and March 2015. Methodology: This study included 108 patients (35 men, 73 women; age range is 46-90 years) and 20 volunteers over 45 years (11 men, 9 women, mean age is 54.3±1.6 years). We compared the parameters of systemic inflammation (blood plasma concentrations of interleukins (IL-6, IL-8, IL-10), tumor necrosis factor α (TNFα), C-reactive protein (CRP) and stable metabolites of nitric oxide (nitrite- and nitrate-ions, NOx) in patients with PIBBC including transient ischemic attack (TIA) and cerebral hypertensive crisis (CHC), patients with lacunar stroke (LS) on the first and tenth day of patient staying in the hospital and in volunteers of a control group. Results: On the first day, the IL-6 and CRP levels for PIBBC and LS groups was found to be significantly higher than the corresponding parameters for a control group. An increase in IL-6 level during the 10-day therapeutic period was observed only in blood plasma of the LS group persons. The TNF-α level was about zero level for all the studied groups except for the LS group on the tenth day. On the first day, for the patients with LS the IL-8 level was significantly decreased comparing to that for the control group and PIBBC groups and the NOx level was significantly lower than that for CHC group. Both parameters increased in values during the 10-day therapeutic period. No difference between the parameters (NOx and IL-8) for PIBBC and control groups was detected on the first day. Coefficient of reactivity characterizing the systemic inflammation level in patients of all the studied groups was nonzero level and it increased in the LS patients during the therapeutic period.  Conclusion: The obtained data showed an important role a number of inflammation markers (NOx, IL-6, IL-8, TNF-α, CRP) in the pathogenesis of different stroke episodes. Absence of specific neuroimaging changes in TIA and CHC group and nonzero coefficient of reactivity (kR) suggests that systemic inflammation is not a result of the focal brain ischemia but its intrinsic cause. The differences in the concentration of IL-8, and NOx in the blood plasma of patients with CHC and LS on their admission to the hospital will help to identify sanogenetic reserves in the case of PIBBC.

Transient ischemic attack cerebral hypertensive crisis lacunar stroke systemic inflammation

References (39)

  1. 1 Guidelines for the Early Management of Patients With Acute Ischemic Stroke [DOI]
  2. 2 Peroxynitrite: biochemistry, pathophysiology and development of therapeutics [DOI]
  3. 3 C-reactive Protein [DOI]
  4. 4 The Vascular Endothelium and Human Diseases [DOI]
  5. 5 Tumor Necrosis Factor-α [DOI]
  6. 6 Function of C-reactive protein [DOI]
  7. 7 Proinflammatory Cytokines and Early Neurological Worsening in Ischemic Stroke [DOI]
  8. 8 Linking endothelial dysfunction with endothelial cell activation [DOI]
  9. 9 Role of Inflammation and Its Mediators in Acute Ischemic Stroke [DOI]
  10. 10 The many faces of tumor necrosis factor in stroke [DOI]
  11. 11 Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke [DOI]
  12. 12 Role of inflammatory markers in brain ischemia [DOI]
  13. 13 Interventions for improving modifiable risk factor control in the secondary prevention of stroke [DOI]
  14. 14 The Use of Blood Biomarkers to Predict Poor Outcome After Acute Transient Ischemic Attack or Ischemic Stroke [DOI]
  15. 15 C-Reactive Protein as a Prognostic Marker After Lacunar Stroke [DOI]
  16. 16 Reactive Oxygen Species and Endothelial Activation [DOI]
  17. 17 Endothelial Cell “Memory” of Inflammatory Stimulation: Human Venular Endothelial Cells Store Interleukin 8 in Weibel-Palade Bodies [DOI]
  18. 18 C-Reactive Protein Predicts Further Ischemic Events in First-Ever Transient Ischemic Attack or Stroke Patients With Intracranial Large-Artery Occlusive Disease [DOI]
  19. 19 Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia.
  20. 20 Associations of Proinflammatory Cytokines With the Risk of Recurrent Stroke [DOI]
  21. 21 TNF-α–Induced Tolerance to Ischemic Injury Involves Differential Control of NF-κB Transactivation: The Role of NF-κB Association with p300 Adaptor [DOI]
  22. 22 Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke [DOI]
  23. 23 Biomarkers for Stroke [DOI]
  24. 24 Inflammatory and Hemostatic Biomarkers Associated With Early Recurrent Ischemic Lesions in Acute Ischemic Stroke [DOI]
  25. 25 Relation Between C-Reactive Protein, Homocysteine Levels, Fibrinogen, and Lipoprotein Levels and Leukocyte and Platelet Counts, and 10-Year Risk for Cardiovascular Disease Among Healthy Adults in the USA [DOI]
  26. 26 Transient Ischemic Attack: Definition, Diagnosis, and Risk Stratification [DOI]
  27. 27 C-Reactive Protein and Nitric Oxide Levels in Ischemic Stroke and Its Subtypes: Correlation with Clinical Outcome [DOI]
  28. 28 Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection [DOI]
  29. 29 Predictive role of C reactive protein in stroke recurrence after cardioembolic stroke: the Fukuoka Stroke Registry [DOI]
  30. 30 Transient ischemic attacks characterized by RNA profiles in blood [DOI]
  31. 31 Activated coagulation/fibrinolysis system and platelet function in acute thrombotic stroke patients with increased C-reactive protein levels [DOI]
  32. 32 C-reactive protein predicts further ischemic events in transient ischemic attack patients [DOI]
  33. 33 Expression of IL-6 activity in patients with acute ischemic stroke.
  34. 34 Cardioembolic Stroke Diagnosis Using Blood Biomarkers [DOI]
  35. 35 Tumor Necrosis Factor-α, Interleukin-8 and Interleukin-6 Are Involved in Vascular Endothelial Cell Capillary Tube and Network Formation Induced by Tumor-Associated Macrophages [DOI]
  36. 36 Biomarkers and functional outcomes from ischaemic cerebral events in women: a prospective cohort study [DOI]
  37. 37 Carotid plaque, stroke pathogenesis, and CRP: Treatment of ischemic stroke [DOI]
  38. 38 Stroke-induced Immune Depression–A Randomized Case Control Study in Kashmiri Population of North India [DOI]
  39. 39 Abstract W P351: Plasma Interleukin-6 and C-reactive Protein Are Associated With Acute Diffusion Hyperintensity After Transient Ischemic Attack [DOI]

Cited by 4

THE STATE OF THE PARAMETERS OF NITRITE/NITRATE ION SYNTHESIS IN PATIENTS WITH PASSING INFRINGEMENTS OF BRAIN BLOOD CIRCULATION

N. V. Galinovskaya, M. N. Starodubtseva, M. G. Shitikova · Health and Ecology Issues · 2017

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

9

Page views

0

PDF downloads

4

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.